Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017037740) STABLE MULTIPARTICUATE PHARAMACEUTICAL COMPOSITION OF ROSUVASTATIN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/037740 International Application No.: PCT/IN2016/050287
Publication Date: 09.03.2017 International Filing Date: 31.08.2016
IPC:
A61K 31/20 (2006.01) ,A61K 31/505 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
20
having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Applicants:
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED [IN/IN]; 17/b, Mahal Industrial Estate, Off Mahakali Caves Road, Andheri (East), Mumbai 400093, IN
Inventors:
DHARMADIKARI, Nitin Bhalachandra; IN
ZALA, Yashoraj; IN
GADKARI, Ashwini; IN
Priority Data:
3351/MUM/201501.09.2015IN
Title (EN) STABLE MULTIPARTICUATE PHARAMACEUTICAL COMPOSITION OF ROSUVASTATIN
(FR) COMPOSITION PHARMACEUTIQUE STABLE MULTIPARTICULAIRE DE ROSUVASTATINE
Abstract:
(EN) The invention relates to a stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.
(FR) L'invention concerne une composition pharmaceutique stable multiparticulaire comprenant des granulés, lesdits granulés comprenant un mélange de rosuvastatine ou de ses sels pharmaceutiquement acceptables en tant que principe actif unique, un ou plusieurs modificateurs de libération osmotique, et un ou plusieurs stabilisateurs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)